Generic Oncology Sterile Injectable Market is expected to witness a CAGR of 11.5% And estimated to surpass US$ 27,543.1 Million by 2028

Sterile injectables are pharmaceutical products used to deliver high concentration of a drug into a patient’s body so that the body can metabolize the drug more effectively. It has become one of the most commonly used therapeutic modalities in all areas of medicine. Sterile injectables have helped reduce costs related to treatment and have enabled the introduction of important new drugs into the health care system. It also helps reduce exposure to infection, side effects and wastage of resources due to their ability to form a permanent seal with the walls of blood vessels.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/562

The global generic oncology sterile injectable market size is estimated to be valued at US$ 11,496.7 million in 2019 and is expected to witness a CAGR of 11.5% over the forecast period (2019 – 2027)

Recent Developments

Major players operating in the global generic oncology sterile injectable market are focused on approval and launch of new products to expand their product portfolio. For instance, in November, 2017, Mylan N.V. launched Clofarabine Injection (20 mg/20 mL (1 mg/mL) Single-Dose Vials) for the treatment of refractory acute lymphoblastic leukemia in patients aged 1 year to 21 years.

Global Generic Oncology Sterile Injectable Market: Drivers

Approval and launch of new products is expected to propel growth of the global generic oncology sterile injectable market over the forecast period. For instance, in September 2019, Mylan N.V. launched Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic version of AstraZeneca’s Faslodex Injection, for the treatment of advanced breast cancer in the U.S.

Moreover, high prevalence of cancer is also expected to aid in growth of the global generic oncology sterile injectable market. For instance, according to the Centers of Disease Control and Prevention’s U.S. Cancer Statistics September 2019, around 94,000 women were diagnosed with gynecologic cancer each year, in the U.S., between 2012 and 2016.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/562

Global Generic Oncology Sterile Injectable Market: Opportunities

R&D in sterile injectable drugs is expected to offer lucrative growth opportunities for players in the global generic oncology sterile injectable market. For instance, in June 2019, Pacira Biosciences, Inc. released data from its Phase 3 study, which examined the efficacy and safety of EXPAREL (bupivacaine liposome injectable suspension) as a single-injection interscalene brachial plexus nerve block in patients undergoing total shoulder arthroplasty or rotator cuff repair.

Market Trends:

Major players operating in the global generic oncology sterile injectable market are focused on expanding production capabilities to enhance their market share. For instance, in 2017, Alembic Pharmaceutical Limited launched manufacturing facility in India to manufacture generic oncology products for international market.

Global Generic Oncology Sterile Injectable Market: Restraints

Stringent rules and regulations for manufacturing of sterile oncology injectables, high quality and care required during manufacturing, challenges in storage, packaging, and distribution of oncology sterile injectable are factors restraining the global generic oncology sterile injectable market growth.

Global Generic Oncology Sterile Injectable Market: Competitive Landscape

Major players operating in the global generic oncology sterile injectable market include, Biocon Ltd., Baxter International Inc., Eli Lilly & Company, Hikma Pharmaceuticals PLC, Mylan N.V., Pfizer Inc., Sandoz International GmbH, and Teva Pharmaceutical Industries Ltd. and Pfizer Inc.

Global Generic Oncology Sterile Injectable Market: Segmentation

By Product Type

• Chemotherapy
  • Alkylating Agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
• Monoclonal Antibodies
• Cytokines
• Peptide Hormones

By Disease Indication

• Ovarian Cancer
• Breast Cancer
• Lung Cancer
• Pancreatic Cancer
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/562

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By Disease Indication
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Regulatory Scenario
   • Industry Trend
   • Merger and Acquisitions
   • New Product Approvals/Launch
   • Promotion and Marketing Initiatives
   • PEST Analysis
4. Global Generic Oncology Sterile Injectable Market, By Product Type, 2016 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Chemotherapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Alkylating agents
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Antimetabolites
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Plant Alkaloids
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Antitumor Antibiotics
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Monoclonal Antibodies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Cytokines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Peptide Hormones
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
5. Global Generic Oncology Sterile Injectable Market, By Disease Indication, 2016– 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Ovarian Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Breast Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Lung Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Pancreatic Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
6. Global Generic Oncology Sterile Injectable Market, By Distribution Channel, 2019 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
7. Global Generic Oncology Sterile Injectable Market, By Region, 2019 – 2027, (US$ Million)
   • Introduction
     • Market Share Analysis, By Region, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, By Region, 2017 – 2026
     • Regional Trends
   • North America
     • Market Size and Forecast, By Product Type, 2016 – 2027 , (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • China
       • Japan
       • India
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
       • GCC Countries
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
     • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
       • North Africa
       • Central Africa
       • South Africa